[go: up one dir, main page]

HUP0200092A3 - Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same - Google Patents

Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same

Info

Publication number
HUP0200092A3
HUP0200092A3 HU0200092A HUP0200092A HUP0200092A3 HU P0200092 A3 HUP0200092 A3 HU P0200092A3 HU 0200092 A HU0200092 A HU 0200092A HU P0200092 A HUP0200092 A HU P0200092A HU P0200092 A3 HUP0200092 A3 HU P0200092A3
Authority
HU
Hungary
Prior art keywords
betha
agonist
intermediates
preparation
same
Prior art date
Application number
HU0200092A
Other languages
English (en)
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of HUP0200092A2 publication Critical patent/HUP0200092A2/hu
Publication of HUP0200092A3 publication Critical patent/HUP0200092A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0200092A 1999-02-16 2000-02-16 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same HUP0200092A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3776699 1999-02-16
JP35080199 1999-12-09

Publications (2)

Publication Number Publication Date
HUP0200092A2 HUP0200092A2 (hu) 2002-05-29
HUP0200092A3 true HUP0200092A3 (en) 2003-02-28

Family

ID=26376915

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200092A HUP0200092A3 (en) 1999-02-16 2000-02-16 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same

Country Status (8)

Country Link
US (2) US6515134B1 (hu)
EP (1) EP1153919A4 (hu)
JP (1) JP4676614B2 (hu)
KR (1) KR20010102198A (hu)
AU (1) AU2571300A (hu)
CA (1) CA2362070A1 (hu)
HU (1) HUP0200092A3 (hu)
WO (1) WO2000048997A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100446324B1 (ko) * 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
PT1138685E (pt) * 2000-03-31 2004-08-31 Pfizer Prod Inc Processo para a preparacao de piridinas substituidas
US20040265991A1 (en) * 2001-10-17 2004-12-30 Naoaki Taoka Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
BR0307996A (pt) * 2002-02-27 2004-12-07 Pfizer Prod Inc Processos e intermediários úteis na preparação de receptores de agonistas beta3-adrenérgicos
WO2003093477A1 (en) * 2002-04-30 2003-11-13 Kaneka Corporation Novel carbonyl reductase, gene thereof and use of the same
DE10244811A1 (de) * 2002-09-26 2004-04-08 Bayer Ag Verfahren zur Herstellung von 3-Heteroaryl-3-hydroxy-propansäurederivaten
WO2005005528A1 (en) 2003-07-14 2005-01-20 Frans Nooren Afdichtingssystemen B.V. Composition for the protection of a shaped article against corrosion
US20050050099A1 (en) * 2003-08-22 2005-03-03 Ge Information Systems System and method for extracting customer-specific data from an information network
RU2007106863A (ru) * 2004-08-26 2008-08-27 Пфайзер Инк. (US) Энантиоселективное биопреобразование для получения промежуточных соединений ингибитора белка тирозинкиназы
JP5005672B2 (ja) * 2006-02-28 2012-08-22 株式会社カネカ 新規カルボニル還元酵素、その遺伝子、およびそれらを利用した光学活性アルコールの製造方法
WO2010150946A1 (en) * 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CN103071423B (zh) * 2013-02-19 2015-01-14 齐齐哈尔大学 吡啶氨基甲酰季铵盐表面活性剂及其制备方法
CN104607099B (zh) * 2015-01-16 2016-06-29 齐齐哈尔大学 （3,3’-对苯二氨甲酰基）双n-烷基吡啶溴盐表面活性剂及其制备方法
ITUB20160227A1 (it) * 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo
CN114752634B (zh) * 2022-04-29 2025-02-07 张邦成都生物医药科技有限公司 一种(r)3-丁炔-2-醇衍生物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518937A (it) * 1968-07-31 1972-02-15 Siphar Sa Procedimento per la preparazione di due nuovi esteri
BE791500A (fr) 1971-11-19 1973-05-17 Hoffmann La Roche Procede pour la preparation de 2-(2-aminobenzoyl) pyridines
US3871958A (en) * 1972-03-04 1975-03-18 Ajinomoto Kk Biological method of producing serine and serinol derivatives
DE3743824C2 (de) * 1987-12-23 1997-03-06 Hoechst Ag Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung
GB8928839D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Novel compounds
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
GB2305665A (en) * 1995-09-26 1997-04-16 Merck & Co Inc Selective ß3 agonists for the treatment of diabetes aand obesity
AU7484596A (en) * 1995-11-01 1997-05-22 Merck & Co., Inc. Combination therapy for the treatment of diabetes and obesity
AR007739A1 (es) * 1996-07-22 1999-11-10 Merck & Co Inc Un proceso para la preparacion de n-(r)-(2-hidroxi-2-piridina-3-il-etil) -2-(4-nitro-fenil)-acetamida
US5792871A (en) * 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
US5846791A (en) * 1996-07-22 1998-12-08 Merck & Co., Inc. N-(R)-(2-hydroxy-2-pyridine-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide
KR20000053314A (ko) * 1996-11-14 2000-08-25 디. 제이. 우드, 스피겔 알렌 제이 치환된 피리딘의 제조 방법
ES2203762T3 (es) * 1996-11-14 2004-04-16 Pfizer Inc. Piridinas intermedias utiles en la sintesis de agonistas del receptor adrenergico beta.
US6001856A (en) * 1997-06-13 1999-12-14 Pfizer Inc. β-adrenergic agonists to reduce a wasting condition
EP0920864A1 (en) * 1997-12-03 1999-06-09 Pfizer Products Inc. Combination therapy including a specific beta-3 agonist and an anorectic agent
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist

Also Published As

Publication number Publication date
EP1153919A4 (en) 2002-10-02
EP1153919A1 (en) 2001-11-14
US20030130521A1 (en) 2003-07-10
KR20010102198A (ko) 2001-11-15
US6642387B2 (en) 2003-11-04
AU2571300A (en) 2000-09-04
US6515134B1 (en) 2003-02-04
CA2362070A1 (en) 2000-08-24
JP4676614B2 (ja) 2011-04-27
HUP0200092A2 (hu) 2002-05-29
WO2000048997A1 (fr) 2000-08-24

Similar Documents

Publication Publication Date Title
HUP0200092A3 (en) Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
EG22172A (en) Phthalamide derivatives production intermediates thereof agrohorticultural insecticides and method for using the same
CZ20011855A3 (cs) Derivát substituovaného benzimidazolu, způsob jeho přípravy a jeho použití
IL146579A0 (en) Process for the preparation of herbicidal derivatives
NO20024256D0 (no) Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet
HUP0203246A3 (en) Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU2001274049A1 (en) Process for the preparation of indole derivatives and intermediates of the process
AU6873700A (en) Process for the preparation of benzoxazine derivatives and intermediates therefor
AU4600200A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
HUP0000524A3 (en) Process for the preparation of thiazole derivatives, intermediates and preparation thereof
AU2466700A (en) Process for the preparation of urea
AU7972200A (en) Process for the preparation of urea
AU5404800A (en) Process for the preparation of optically active n-acyl derivatives of methyl n-(2,6-dimethylphenyl)-d-alaninate
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
AU1651001A (en) Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
HUP0202819A3 (en) Process for the preparation of thiazole derivatives and the new intermediates
HU0003979D0 (en) Process for the preparation of 3-pyridylsulphonil-pyrazolo[4,3-d] pyrimidin-7-one derivatives and intermediates thereof
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
EE200000024A (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
AU6727700A (en) Process for the preparation of optically active sulfoxide derivatives
AU5415900A (en) Process for the preparation of butoxycarbonylimino compounds and intermediates therefor